Bd launches next generation hemodynamic monitoring solution providing clinicians with ai-driven clinical decision support

Hemosphere alta™ advanced monitoring platform with predictive, smart algorithms helps clinicians proactively address instability in blood flow and pressure in critical situations franklin lakes, n.j. , april 21, 2025 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, has launched a new advanced hemodynamic monitoring platform with predictive, artificial intelligence (ai) based algorithms that can help clinicians proactively address blood pressure instability and optimize blood flow to help avoid potential life-threatening situations during procedures.
BDX Ratings Summary
BDX Quant Ranking